Imax Corporation Insider Trading

IMAX

Last 12 months

Insiders sold $74.7M and bought nothing on the open market.

54% of the selling was scheduled in advance under 10b5-1 plans. Director Kevin Douglas sold $21.5M on Mar 16, 6.8% of their stake, outside a plan. The last open-market buy by an executive or director was in Mar 2020.

Net open-market

−$74.7M

0 buys · 20 sales

Under a 10b5-1 plan

54%

of the value sold

Insiders who bought / sold

0 / 9

executives and directors

Last open-market buy

Mar 2020

Mar 17, 2020

Get an email when IMAX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 10	Robert D Lister Chief Legal Officer Sr Exec VP	SoldNo plan	22,500	$51.58	$1.16M	5.5%	Form 4
Aug 25	Mark Welton President IMAX Global Theatres	SoldNo plan	30,000	$54.47	$1.63M	8.7%	Form 4
Aug 25	Kenneth Ian Weissman Deputy GC, Corp. Sec. & CCO	SoldNo plan	8,000	$54.54	436K	11%	Form 4
Aug 24	Natasha Fernandes Chief Financial Officer & EVP	SoldNo plan	20,000	$54.63	$1.09M	18%	Form 4
Aug 20	Calamera Pablo CTO & EVP	SoldNo plan	15,000	$52.41	786K	13%	Form 4
Aug 18 – 20	Richard L Gelfond Chief Executive Officer	Sold10b5-1 plan 3 parts	456,757	$52.51 average	$24M	24%	Form 4
Aug 6	Jose Aleksandr Zlatar SVP, Controller & PAO	SoldNo plan	500	$49.90	25K	23%	Form 4
Apr 27	Richard L Gelfond Chief Executive Officer	Sold10b5-1 plan	8,943	$37.33	334K	0.6%	Form 4
Apr 16 – 17	Richard L Gelfond Chief Executive Officer	Sold10b5-1 plan 2 parts	75,919	$37.05 average	$2.81M	4.7%	Form 4
Apr 13 – 15	Richard L Gelfond Chief Executive Officer	Sold10b5-1 plan 3 parts	120,132	$37.13 average	$4.46M	7.3%	Form 4
Apr 10	Richard L Gelfond Chief Executive Officer	Sold10b5-1 plan	135,046	$37.82	$5.11M	8.1%	Form 4
Apr 2 – 6	Richard L Gelfond Chief Executive Officer	Sold10b5-1 plan 2 parts	25,024	$40.13 average	$1M	1.6%	Form 4
Mar 16	Kevin Douglas Director	SoldNo plan 6 parts	568,000	$37.82 average	$21.5M	6.8%	Form 4
Mar 10	Richard L Gelfond Chief Executive Officer	SoldNo plan	121,220	$40.10	$4.86M	7.3%	Form 4
Dec 15, 2025	Mark Welton President IMAX Global Theatres	Sold10b5-1 plan	25,000	$39.28	982K	8.2%	Form 4
Nov 24, 2025	Natasha Fernandes Chief Financial Officer & EVP	SoldNo plan	2,652	$36.15	96K	4.1%	Form 4
Nov 10, 2025	Mark Welton President IMAX Global Theatres	SoldNo plan	49,504	$35.23	$1.74M	14%	Form 4
Nov 10, 2025	Giovanni M. Dolci Chief Commercial Officer & EVP	SoldNo plan	6,188	$34.25	212K	8.6%	Form 4
Nov 10, 2025	Calamera Pablo CTO & EVP	SoldNo plan	20,586	$34.23	705K	17%	Form 4
Nov 7, 2025	Robert D Lister Chief Legal Officer Sr Exec VP	Sold10b5-1 plan	50,143	$34.67	$1.74M	13%	Form 4
Sep 15, 2025	Robert D Lister Chief Legal Officer Sr Exec VP	Sold10b5-1 plan	20,000	$32.80	656K	5.5%	Form 4
Aug 14, 2025	Kenneth Ian Weissman Deputy GC, Corp. Sec. & CCO	SoldNo plan 2 parts	15,072	$25.65 average	387K	20%	Form 4
Aug 5, 2025	Giovanni M. Dolci Chief Commercial Officer	SoldNo plan	6,500	$25.00	163K	8.2%	Form 4
May 19, 2025	Richard L Gelfond Chief Executive Officer	SoldNo plan	100,000	$27.11	$2.71M	7.1%	Form 4
Feb 24, 2025	Eric A Demirian Director	SoldNo plan	23,000	$26.81	617K	20%	Form 4
Dec 9, 2024	Natasha Fernandes Chief Financial Officer & EVP	SoldNo plan	2,957	$25.52	75K	9.0%	Form 4
Dec 9, 2024	Kenneth Ian Weissman Deputy GC, Corp. Sec. & CCO	SoldNo plan	6,309	$25.51	161K	11%	Form 4
Dec 9, 2024	Mark Welton President, IMAX Theatres	SoldNo plan	39,432	$25.51	$1.01M	15%	Form 4
Dec 9, 2024	Robert D Lister Chief Legal Officer & Sr. EVP	SoldNo plan	55,910	$25.50	$1.43M	17%	Form 4

Sep 10No plan
Robert D Lister
Chief Legal Officer Sr Exec VP · sold 22,500 at $51.58
$1.16M
5.5% of stake
Aug 25No plan
Mark Welton
President IMAX Global Theatres · sold 30,000 at $54.47
$1.63M
8.7% of stake
Aug 25No plan
Kenneth Ian Weissman
Deputy GC, Corp. Sec. & CCO · sold 8,000 at $54.54
436K
11% of stake
Aug 24No plan
Natasha Fernandes
Chief Financial Officer & EVP · sold 20,000 at $54.63
$1.09M
18% of stake
Aug 20No plan
Calamera Pablo
CTO & EVP · sold 15,000 at $52.41
786K
13% of stake
Aug 18 – 2010b5-1 plan
Richard L Gelfond
Chief Executive Officer · sold 456,757 at avg $52.51
$24M
24% of stake
Aug 6No plan
Jose Aleksandr Zlatar
SVP, Controller & PAO · sold 500 at $49.90
25K
23% of stake
Apr 2710b5-1 plan
Richard L Gelfond
Chief Executive Officer · sold 8,943 at $37.33
334K
0.6% of stake
Apr 16 – 1710b5-1 plan
Richard L Gelfond
Chief Executive Officer · sold 75,919 at avg $37.05
$2.81M
4.7% of stake
Apr 13 – 1510b5-1 plan
Richard L Gelfond
Chief Executive Officer · sold 120,132 at avg $37.13
$4.46M
7.3% of stake
Apr 1010b5-1 plan
Richard L Gelfond
Chief Executive Officer · sold 135,046 at $37.82
$5.11M
8.1% of stake
Apr 2 – 610b5-1 plan
Richard L Gelfond
Chief Executive Officer · sold 25,024 at avg $40.13
$1M
1.6% of stake
Mar 16No plan
Kevin Douglas
Director · sold 568,000 at avg $37.82
$21.5M
6.8% of stake
Mar 10No plan
Richard L Gelfond
Chief Executive Officer · sold 121,220 at $40.10
$4.86M
7.3% of stake
Dec 15, 202510b5-1 plan
Mark Welton
President IMAX Global Theatres · sold 25,000 at $39.28
982K
8.2% of stake
Nov 24, 2025No plan
Natasha Fernandes
Chief Financial Officer & EVP · sold 2,652 at $36.15
96K
4.1% of stake
Nov 10, 2025No plan
Mark Welton
President IMAX Global Theatres · sold 49,504 at $35.23
$1.74M
14% of stake
Nov 10, 2025No plan
Giovanni M. Dolci
Chief Commercial Officer & EVP · sold 6,188 at $34.25
212K
8.6% of stake
Nov 10, 2025No plan
Calamera Pablo
CTO & EVP · sold 20,586 at $34.23
705K
17% of stake
Nov 7, 202510b5-1 plan
Robert D Lister
Chief Legal Officer Sr Exec VP · sold 50,143 at $34.67
$1.74M
13% of stake
Sep 15, 202510b5-1 plan
Robert D Lister
Chief Legal Officer Sr Exec VP · sold 20,000 at $32.80
656K
5.5% of stake
Aug 14, 2025No plan
Kenneth Ian Weissman
Deputy GC, Corp. Sec. & CCO · sold 15,072 at avg $25.65
387K
20% of stake
Aug 5, 2025No plan
Giovanni M. Dolci
Chief Commercial Officer · sold 6,500 at $25.00
163K
8.2% of stake
May 19, 2025No plan
Richard L Gelfond
Chief Executive Officer · sold 100,000 at $27.11
$2.71M
7.1% of stake
Feb 24, 2025No plan
Eric A Demirian
Director · sold 23,000 at $26.81
617K
20% of stake
Dec 9, 2024No plan
Natasha Fernandes
Chief Financial Officer & EVP · sold 2,957 at $25.52
75K
9.0% of stake
Dec 9, 2024No plan
Kenneth Ian Weissman
Deputy GC, Corp. Sec. & CCO · sold 6,309 at $25.51
161K
11% of stake
Dec 9, 2024No plan
Mark Welton
President, IMAX Theatres · sold 39,432 at $25.51
$1.01M
15% of stake
Dec 9, 2024No plan
Robert D Lister
Chief Legal Officer & Sr. EVP · sold 55,910 at $25.50
$1.43M
17% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IMAX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Photographic Equipment & Supplies · Pick stocks to compare with IMAX

CompareIntrinsic value

GPROGoPro Inc.

$0.95-1.52%10

KODKEastman Kodak Company

$7.51-13.38%55

ARAYAccuray Incorporated

$0.15+7.14%0

INMDInMode Ltd.

$14.20+0.85%48

AORTArtivion Inc.

$26.45+11.56%29

MDXGMiMedx Group, Inc.

$3.25-0.91%18

INGNInogen Inc.

$7.22+2.85%25

TCMDTactile Systems Technology Inc.

$27.20+9.75%73

Held by ETFs

IMAX is in 41 US ETFs. The largest of them, with IMAX's weight in each:

Spot a number that looks wrong? Check it in IMAX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IMAX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.